Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Insights: Geriatric and QoL Assessments on Gem/Nab-Pac vs. 5-FU/Leucovorin/Liposomal Irinotecan in Older Patients With mPDAC - GIANT Study Results
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Efrat Dotan
By
Insights from 2025 ASCO® GI Annual Meeting
FEATURING
Efrat Dotan
Comments 0
Login to view comments.
Click here to Login
